Ventas, Inc. (VTR)

VTR gains momentum as its healthcare real estate portfolio, research investments and solid balance sheet point to further growth potential.

Axa S.A. lifted its holdings in Ventas, Inc. (NYSE: VTR) by 58.8% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 333,388 shares of the real estate investment trust's stock after acquiring an additional 123,395 shares during the quarter. Axa S.A.

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) today announced that its Board of Directors has declared a quarterly dividend of $0.48 per common share. The dividend will be payable in cash on January 15, 2026, to stockholders of record as of the close of business on December 31, 2025. About Ventas Ventas, Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 propert.

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will participate in investor meetings at Nareit's REITworld 2025 Annual Conference (the “Nareit Conference”) on December 8-9, 2025. Written materials that the Company expects to use in connection with its participation at the Nareit Conference will be made available on the Company's website on Monday, December 8, 2025 at 8:30 a.m. Eastern Time. Such materials will be archived at ir.ven.

Demand tailwinds from the aging Baby Boomer cohort and record-low new construction underpin a multi-year runway for double-digit internal and external growth. Premiums to NAV enable accretive acquisitions, and current valuations underestimate the durability and longevity of the SH cycle for these REITs. VTR, WELL, and AHR are best positioned to benefit from exceptional internal growth combined with robust and accretive external growth.

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that its wholly owned subsidiary, Ventas Realty, Limited Partnership (“Ventas Realty”), has priced an underwritten public offering of $500.0 million aggregate principal amount of 5.000% Senior Notes due 2036 (the “Notes”) at an issue price equal to 99.510% of the principal amount of the Notes. The Notes will be senior unsecured obligations of Ventas Realty and will be fully and unconditionally guarant.

Ventas, Inc. (NYSE: VTR - Get Free Report)'s stock price reached a new 52-week high during trading on Friday. The company traded as high as $80.67 and last traded at $80.4440, with a volume of 28599 shares trading hands. The stock had previously closed at $80.08. Analysts Set New Price Targets Several analysts recently issued

Ventas (NYSE: VTR - Get Free Report) and CareTrust REIT (NYSE: CTRE - Get Free Report) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, analyst recommendations and dividends. Volatility and Risk Ventas has a beta of 0.88,

Ventas (VTR) reported earnings 30 days ago. What's next for the stock?

Does Ventas (VTR) have what it takes to be a top stock pick for momentum investors? Let's find out.

B&I Capital AG lifted its holdings in shares of Ventas, Inc. (NYSE: VTR) by 5.1% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 150,200 shares of the real estate investment trust's stock after buying an additional 7,350 shares during the period. Ventas comprises

AlphaCore Capital LLC acquired a new position in shares of Ventas, Inc. (NYSE: VTR) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 2,562 shares of the real estate investment trust's stock, valued at approximately $161,000. A number of other large investors have

The REIT sector has seen back-to-back tough months as it saw a modest average negative total return in September (-0.73%) and fell deeper into the red in October (-4.03%). Small cap REITs (-5.05%) had the worst performance in October. Micro caps (-2.81%), mid caps (-3.11%) and large caps (-4.45%) were also in negative territory albeit to a smaller degree. Only 21.66% of REIT securities had a positive total return in October.

VTR's expanding SHOP footprint, rising cash NOI and active capital recycling underscore its growth momentum.

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research and Chief Executive Officer of Lillibridge Healthcare Services, has informed the Company of his intention to retire on May 1, 2026. Ventas will commence a search process to identify a successor. “Pete has been instrumental in elevating and driving excellence across our Outpatient Medical & Research and Lillibridg.

Allworth Financial LP raised its stake in shares of Ventas, Inc. (NYSE: VTR) by 126.7% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 7,038 shares of the real estate investment trust's stock after buying an additional 3,933 shares during the period. Allworth Financial LP's